Literature DB >> 32901250

Heaping the Pelion of Vancomycin on the Ossa of Methicillin-resistant Staphylococcus aureus: Back to Basics in Clinical Care and Guidelines.

William F Wright1, Sarah C J Jorgensen2, Brad Spellberg3.   

Abstract

Entities:  

Keywords:  PK-PD; clinical practice; guidelines; pharmacology; vancomycin

Mesh：

Substances：

Year:  2021        PMID： 32901250      PMCID： PMC8130018          DOI： 10.1093/cid/ciaa1360

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   20.999


× No keyword cloud information.
  31 in total

1.  Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael J Rybak; Ben M Lomaestro; John C Rotschafer; Robert C Moellering; Willam A Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

2.  Examining the Relationship Between Vancomycin Area Under the Concentration Time Curve and Serum Trough Levels in Adults With Presumed or Documented Staphylococcal Infections.

Authors:  Laura Clark; Lee P Skrupky; Ryan Servais; Charles F Brummitt; Thomas J Dilworth
Journal:  Ther Drug Monit       Date:  2019-08       Impact factor: 3.681

3.  Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens.

Authors:  Issam Raad; Rabih Darouiche; Jose Vazquez; Arnold Lentnek; Ray Hachem; Hend Hanna; Beth Goldstein; Tim Henkel; Elyse Seltzer
Journal:  Clin Infect Dis       Date:  2005-01-07       Impact factor: 9.079

4.  Evaluation of Target Attainment of Vancomycin Area Under the Curve in Children With Methicillin-Resistant Staphylococcus Aureus Bacteremia.

Authors:  Andrea Hahn; Robert W Frenck; Mary Allen-Staat; Yuanshu Zou; Alexander A Vinks
Journal:  Ther Drug Monit       Date:  2015-10       Impact factor: 3.681

5.  Optimizing Vancomycin Use Through 2-Point AUC-Based Therapeutic Drug Monitoring in Pediatric Patients.

Authors:  Pintip Suchartlikitwong; Suvaporn Anugulruengkitt; Noppadol Wacharachaisurapol; Watsamon Jantarabenjakul; Jiratchaya Sophonphan; Tuangtip Theerawit; Tanittha Chatsuwan; Thitima Wattanavijitkul; Thanyawee Puthanakit
Journal:  J Clin Pharmacol       Date:  2019-07-24       Impact factor: 3.126

6.  Association between vancomycin trough concentration and area under the concentration-time curve in neonates.

Authors:  Adam Frymoyer; Adam L Hersh; Mohammed H El-Komy; Shabnam Gaskari; Felice Su; David R Drover; Krisa Van Meurs
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

7.  Is Trough Concentration of Vancomycin Predictive of the Area Under the Curve? A Clinical Study in Elderly Patients.

Authors:  Anis Bel Kamel; Laurent Bourguignon; Micaela Marcos; Michel Ducher; Sylvain Goutelle
Journal:  Ther Drug Monit       Date:  2017-02       Impact factor: 3.681

8.  Impact of vancomycin protein binding on target attainment in critically ill children: back to the drawing board?

Authors:  Pieter A J G De Cock; Sarah Desmet; Annick De Jaeger; Dominique Biarent; Evelyn Dhont; Ingrid Herck; Daphné Vens; Sofie Colman; Veronique Stove; Sabrina Commeyne; Johan Vande Walle; Peter De Paepe
Journal:  J Antimicrob Chemother       Date:  2017-03-01       Impact factor: 5.790

9.  Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Alex Soriano; Francesc Marco; José A Martínez; Elena Pisos; Manel Almela; Veselka P Dimova; Dolores Alamo; Mar Ortega; Josefina Lopez; Josep Mensa
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

10.  Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals.

Authors:  Cornelis Smit; Roeland E Wasmann; Sebastiaan C Goulooze; Marinus J Wiezer; Eric P A van Dongen; Johan W Mouton; Roger J M Brüggemann; Catherijne A J Knibbe
Journal:  Br J Clin Pharmacol       Date:  2020-01-07       Impact factor: 4.335
View more
  2 in total

1.  Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults: A WikiGuidelines Group Consensus Statement.

Authors:  Brad Spellberg; Gloria Aggrey; Meghan B Brennan; Brent Footer; Graeme Forrest; Fergus Hamilton; Emi Minejima; Jessica Moore; Jaimo Ahn; Michael Angarone; Robert M Centor; Kartikeya Cherabuddi; Jennifer Curran; Kusha Davar; Joshua Davis; Mei Qin Dong; Bassam Ghanem; Doug Hutcheon; Philipp Jent; Minji Kang; Rachael Lee; Emily G McDonald; Andrew M Morris; Rebecca Reece; Ilan S Schwartz; Miranda So; Steven Tong; Christopher Tucker; Noah Wald-Dickler; Erica J Weinstein; Riley Williams; Christina Yen; Shiwei Zhou; Todd C Lee
Journal:  JAMA Netw Open       Date:  2022-05-02

2.  Systematic Comparison of Hospital-Wide Standard and Model-Based Therapeutic Drug Monitoring of Vancomycin in Adults.

Authors:  Heleen Gastmans; Erwin Dreesen; Sebastian G Wicha; Nada Dia; Ellen Spreuwers; Annabel Dompas; Karel Allegaert; Stefanie Desmet; Katrien Lagrou; Willy E Peetermans; Yves Debaveye; Isabel Spriet; Matthias Gijsen
Journal:  Pharmaceutics       Date:  2022-07-13       Impact factor: 6.525
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.